A Single-dose, Randomized, Open-label, Three-sequence, Three-period Crossover Clinical Trial to Evaluate the Effect of High-fat and Low-fat Meals on the Pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects.
Latest Information Update: 08 Apr 2026
At a glance
- Drugs Ammoxetine hydrochloride (Primary)
- Indications Major depressive disorder
- Focus Pharmacokinetics
- Sponsors CSPC ZhongQi Pharmaceutical Technology
Most Recent Events
- 08 Apr 2026 New trial record